Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3979313 | Bulletin du Cancer | 2010 | 11 Pages |
Abstract
The fact that irinotecan may be linked to an increased risk of hepatic failure and postoperative death, which is not the case of oxaliplatine, must be took in consideration in the choice of the preoperative chemotherapy before resection of hepatic metastasis of colorectal cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
I. Baumgaertner, V. Ratziu, J.-C. Vaillant, L. Hannoun, T. Poynard, T. André,